Outcome after bevacizumab clinical trial
Outcome after bevacizumab clinical trial therapy among recurrent grade III malignant glioma patients
β
David A. Reardon; James E. Herndon; Katherine Peters; Annick Desjardins; April C
π
Article
π
2011
π
Springer US
π
English
β 261 KB